Integrins mediate adherence and migration of T lymphocytes on human peritoneal mesothelial cells

Kidney International

Volumn 74, Issue 6, 2008, Pages 808-816

  Wang, Hsin Hui ^a,b   Lee, Tzong Yann ^c,d   Lin, Ching Yuang ^e,f  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c EN CHU KONG HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

4 1; 6 1; Integrin; Migration; Peritoneal mesothelial cells; T cells

Indexed keywords

INTEGRIN; LIPOPOLYSACCHARIDE; PROTEIN ANTIBODY; VERY LATE ACTIVATION ANTIGEN 4; VERY LATE ACTIVATION ANTIGEN 6;

ARTICLE; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; EFFLUENT; HUMAN; HUMAN CELL; INFLAMMATION; MESOTHELIUM CELL; MONOLAYER CULTURE; PERITONEAL DIALYSIS; PERITONEUM CELL; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; TH1 CELL;

ASCITIC FLUID; CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; EPITHELIAL CELLS; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRIN ALPHA6BETA1; INTEGRINS; LIPOPOLYSACCHARIDES; PERITONEAL CAVITY; PERITONEUM; PERITONITIS; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 50849089922     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.330     Document Type: Article

References (57)

1. Gokal R, Mallick NP. Peritoneal dialysis. Lancet 1999; 353: 823-828.
2. Fried LF, Bernardini J, Johnston JR et al. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7: 2176-2182.
3. Maiorca R, Vonesh EF, Cavalli P et al. A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int 1991; 11: 118-127.
4. Abdel-Rahman EM, Wakeen M, Zimmerman SW. Characteristics of long-term peritoneal dialysis survivors: 18 years experience in one center. Perit Dial Int 1997; 17: 151-156.
5. Tranaeus A, Heimburger O, Lindholm B. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): diagnostic findings, therapeutic outcome and complications. Perit Dial Int 1989; 9: 179-190.
6. Davies SJ, Bryan J, Phillips L et al. Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 1996; 11: 498-506.
7. Piraino B. Peritonitis as a complication of peritoneal dialysis. J Am Soc Nephrol 1998; 9: 1956-1964.
8. Broche F, Tellado JM. Defense mechanisms of the peritoneal cavity. Curr Opin Crit Care 2001; 7: 105-116.
9. Holmes CJ. Peritoneal host defense mechanisms in peritoneal dialysis. Kidney Int Suppl 1994; 48: S58-S70.
10. Topley N. The cytokine network controlling peritoneal inflammation. Perit Dial Int 1995; 15: S35-S39; discussion S39-40.
11. Li FK, Davenport A, Robson RL et al. Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression. Kidney Int 1998; 54: 2170-2183.
12. Visser CE, Tekstra J, Brouwer-Steenbergen JJ et al. Chemokines produced by mesothelial cells: huGRO-alpha, IP-10, MCP-1 and RANTES. Clin Exp Immunol 1998; 112: 270-275.
13. Tekstra J, Visser CE, Tuk CW et al. Identification of the major chemokines that regulate cell influxes in peritoneal dialysis patients. J Am Soc Nephrol 1996; 7: 2379-2384.
14. Betjes MG, Visser CE, Zemel D et al. Intraperitoneal interleukin-8 and neutrophil influx in the initial phase of a CAPD peritonitis. Perit Dial Int 1996; 16: 385-392.
15. Topley N, Williams JD. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int Suppl 1994; 48: S71-S78.
16. Liberek T, Topley N, Luttmann W et al. Adherence of neutrophils to human peritoneal mesothelial cells: role of intercellular adhesion molecule-1. J Am Soc Nephrol 1996; 7: 208-217.
17. Jonjic N, Peri G, Bernasconi S et al. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 1992; 176: 1165-1174.
18. Andreoli SP, Mallett C, Williams K et al. Mechanisms of polymorphonuclear leukocyte mediated peritoneal mesothelial cell injury. Kidney Int 1994; 46: 1100-1109.
19. Cannistra SA, Ottensmeier C, Tidy J et al. Vascular cell adhesion molecule-1 expressed by peritoneal mesothelium partly mediates the binding of activated human T lymphocytes. Exp Hematol 1994; 22: 996-1002.
20. Betjes MG, Tuk CW, Visser CE et al. Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitis. Nephrol Dial Transplant 1994; 9: 684-692.
21. Betjes MG, Tuk CW, Struijk DG et al. Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study. Kidney Int 1993; 43: 641-648.
22. Zeillemaker AM, Mul FP, Hoynck van Papendrecht AA et al. Neutrophil adherence to and migration across monolayers of human peritoneal mesothelial cells. The role of mesothelium in the influx of neutrophils during peritonitis. J Lab Clin Med 1996; 127: 279-286.
23. Robson RL, McLoughlin RM, Witowski J et al. Differential regulation of chemokine production in human peritoneal mesothelial cells: IFN-gamma controls neutrophil migration across the mesothelium in vitro and in vivo. J Immunol 2001; 167: 1028-1038.
24. Witowski J, Pawlaczyk K, Breborowicz A et al. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 2000; 165: 5814-5821.
25. Dasgupta MK, Larabie M, Halloran PF. Interferon-gamma levels in peritoneal dialysis effluents: relation to peritonitis. Kidney Int 1994; 46: 475-481.
26. Wang HH, Lin CY, Huang TP. Patterns of CD4/CD8 T-cell ratio in dialysis effluents predict the long-term outcome of peritonitis in patients undergoing peritoneal dialysis. Nephrol Dial Transplant 2003; 18: 1181-1189.
27. Wang HH, Lin CY. Interleukin-12 and -18 levels in peritoneal dialysate effluent correlate with the outcome of peritonitis in patients undergoing peritoneal dialysis: implications for the Type I/Type II T-cell immune response. Am J Kidney Dis 2005; 46: 328-338.
28. Hausmann MJ, Rogachev B, Weiler M et al. Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth. Kidney Int 2000; 57: 476-486.
29. Basok A, Shnaider A, Man L et al. CD40 is expressed on human peritoneal mesothelial cells and upregulates the production of interleukin-15 and RANTES. J Am Soc Nephrol 2001; 12: 695-702.
30. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992; 69: 11-25.
31. Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J 1990; 4: 2868-2880.
32. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987; 48: 549-554.
33. Ruoslahti E. Integrins. J Clin Invest 1991; 87: 1-5.
34. Hogg N, Laschinger M, Giles K et al. T-cell integrins: more than just sticking points. J Cell Sci 2003; 116: 4695-4705.
35. von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. N Engl J Med 2000; 343: 1020-1034.
36. Westermann J, Engelhardt B, Hoffmann JC. Migration of T cells in vivo: molecular mechanisms and clinical implications. Ann Intern Med 2001; 135: 279-295.
37. Faull RJ, Ginsberg MH. Inside-out signaling through integrins. J Am Soc Nephrol 1996; 7: 1091-1097.
38. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science 1995; 268: 233-239.
39. D'Ambrosio D, Iellem A, Colantonio L et al. Localization of Th-cell subsets in inflammation: differential thresholds for extravasation of Th1 and Th2 cells. Immunol Today 2000; 21: 183-186.
40. Colantonio L, Iellem A, Clissi B et al. Upregulation of integrin alpha6/ beta1 and chemokine receptor CCR1 by interleukin-12 promotes the migration of human type 1 helper T cells. Blood 1999; 94: 2981-2989.
41. Clissi B, D'Ambrosio D, Geginat J et al. Chemokines fail to up-regulate beta 1 integrin-dependent adhesion in human Th2 T lymphocytes. J Immunol 2000; 164: 3292-3300.
42. Lim YC, Wakelin MW, Henault L et al. Alpha4beta1-integrin activation is necessary for high-efficiency T-cell subset interactions with VCAM-1 under flow. Microcirculation 2000; 7: 201-214.
43. Pulendran B, Kumar P, Cutler CW et al. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 2001; 167: 5067-5076.
44. Agrawal S, Agrawal A, Doughty B et al. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 2003; 171: 4984-4989.
45. Cervi L, MacDonald AS, Kane C et al. Cutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J Immunol 2004; 172: 2016-2020.
46. Jotwani R, Pulendran B, Agrawal S et al. Human dendritic cells respond to Porphyromonas gingivalis LPS by promoting a Th2 effector response in vitro. Eur J Immunol 2003; 33: 2980-2986.
47. Tulic MK, Fiset PO, Manoukian JJ et al. Role of toll-like receptor 4 in protection by bacterial lipopolysaccharide in the nasal mucosa of atopic children but not adults. Lancet 2004; 363: 1689-1697.
48. Andersson AC, Seppala U, Rudin A. Activation of human neonatal monocyte-derived dendritic cells by lipopolysaccharide down-regulates birch allergen-induced Th2 differentiation. Eur J Immunol 2004; 34: 3516-3524.
49. Kuipers H, Hijdra D, De Vries VC et al. Lipopolysaccharide-induced suppression of airway Th2 responses does not require IL-12 production by dendritic cells. J Immunol 2003; 171: 3645-3654.
50. Castro AG, Neighbors M, Hurst SD et al. Anti-interleukin 10 receptor monoclonal antibody is an adjuvant for T helper cell type 1 responses to soluble antigen only in the presence of lipopolysaccharide. J Exp Med 2000; 192: 1529-1534.
51. Ausiello CM, Fedele G, Urbani F et al. Native and genetically inactivated Pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses. J Infect Dis 2002; 186: 351-360.
52. Huang L, Krieg AM, Eller N et al. Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heat-inactivated bacteria. Infect Immun 1999; 67: 6257-6263.
53. Kato S, Yuzawa Y, Tsuboi N et al. Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4. J Am Soc Nephrol 2004; 15: 1289-1299.
54. Ginsberg MH, Du X, Plow EF. Inside-out integrin signalling. Curr Opin Cell Biol 1992; 4: 766-771.
55. Stylianou E, Jenner LA, Davies M et al. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37: 1563-1570.
56. Tarnvik A, Holm SE. Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis. Infect Immun 1978; 20: 698-704.
57. Bonecchi R, Bianchi G, Bordignon PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998; 187: 129-134.